In the crowded wards and clinics of Southeast Asia, a doctor's time is the scarcest resource. For Dorothea Koh and Yan Chuan Sim, the co-founders of Bot MD, the most critical piece of clinical infrastructure is a smartphone loaded with an AI assistant that knows the hospital's own protocols, drug formularies, and on-call rosters. Since its 2018 founding and a Y Combinator stint, the Singapore-based healthtech startup has pursued a pragmatic, integration-heavy wedge: becoming the default digital sidekick for physicians navigating fragmented hospital systems [TechCrunch, Feb 2021].
The Wedge: Integration, Not Invention
Bot MD's bet is on organizing and surfacing the knowledge that already exists within a hospital's walls. The core product is a smartphone-based AI assistant that integrates with a facility's internal systems, protocols, guidelines, and lab catalogues, allowing a doctor to ask, via natural language, which antibiotic is on formulary or what the step-down protocol is for a specific condition [Crunchbase]. The company's second offering, Bot MD Care, launched in 2020, automates workflows like appointment scheduling, referral management, and remote patient monitoring through popular chat platforms like WhatsApp and Viber [Perplexity Sonar]. The company claims its automation can boost hospital revenue by 20-30% by handling routine inquiries and follow-ups [Perplexity Sonar].
Traction in a Fragmented Landscape
Bot MD says its tools are used by more than 20,000 doctors and nurses globally and have touched over 100,000 patients across Southeast Asia [Tatler Asia] [Bot MD website]. Its case studies point to substantive deployments: powering instant information search for 1,000 staff at Singapore's Tan Tock Seng Hospital and remotely monitoring over 2,000 peritoneal dialysis patients in the Philippines [Bot MD news] [Bot MD case studies]. Revenue generation is claimed to exceed $3 million from automating scheduling and GP referrals for hospital chains [Bot MD case studies]. The company's $5 million Series A in 2021, led by Monk's Hill Ventures, provided capital to expand this model [TechCrunch, Feb 2021].
The Team and Technical Core
Founder-CEO Dorothea Koh drives the commercial and clinical vision, while co-founder Yan Chuan Sim, as CTO, built the natural language processing chat engine [Perplexity Sonar]. Their approach leans heavily on partnerships for data and distribution. Bot MD's training data comes from hospital partners' internal systems as well as licensed professional resources like UpToDate and the American Society of Hospital Pharmacists database [Perplexity Sonar]. A partnership with the Indonesian Medical Association aims to provide the AI assistant to over 200,000 doctors [Tatler Asia]. The company's footprint is estimated at 27 employees [ZoomInfo].
| Role | Name | Key Background / Note |
|---|---|---|
| Co-Founder & CEO | Dorothea Koh | Leads commercial strategy and clinical engagement. |
| Co-Founder & CTO | Yan Chuan (YC) Sim | Built the proprietary NLP chat engine for clinical search. |
Where the Model Faces Pressure
Bot MD operates in a space with clear competitive and operational risks. Its model depends on deep, ongoing technical integrations with each hospital's unique IT stack, which can be slow and costly. While avoiding the regulatory burden of a novel clinical decision support tool is a strategic choice, it also means the product's 'stickiness' is tied to workflow convenience rather than proprietary medical insight. The company's public news flow has been quiet since its 2021 fundraise, which raises questions about its growth pace and ability to capture larger, enterprise-wide contracts beyond departmental pilots.
The Standard of Care Today
For a physician managing a heavy patient load in Manila or Jakarta, the standard of care for information retrieval is often a manual hunt. It involves logging into multiple, siloed hospital systems, searching PDF manuals, calling the pharmacy, or paging a specialist. Bot MD's bet is that by consolidating these disparate threads into a single, conversational interface, it can reclaim time for doctors and improve adherence for patients. It is a bet on operational efficiency and access, aiming to make existing care protocols more reliably executed.